Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002791 · ClinicalTrials.gov registry record · Phase 2
Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
A Phase 2 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002791: Completed Phase 2 study, sponsored by Radiation Therapy Oncology Group.
NCT00002791 is a Phase 2 study that has completed, run by Radiation Therapy Oncology Group. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002791, a Phase 2 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with more than one chemotherapy drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus radiation therapy followed by surgery in treating patients who have soft tissue sarcoma.
Interventions
- DRUG ifosfamide
- DRUG dacarbazine
- BIOLOGICAL filgrastim
- DRUG doxorubicin hydrochloride
- DRUG mesna
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-02 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
What the finished NCT00002791 record still lists
NCT00002791 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 5 interventions - of which ifosfamide is the first listed.
NCT00002791 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002791 about?
NCT00002791 is a clinical study titled "Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with more than one chemotherapy drug may kill more tumor cells. PURPOSE: Phase II tria...
What is the current status of trial NCT00002791?
This trial is currently completed. It is a Phase 2 study. The study started on 1997-02. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00002791?
The interventions under investigation include: ifosfamide (DRUG), dacarbazine (DRUG), filgrastim (BIOLOGICAL), doxorubicin hydrochloride (DRUG), mesna (DRUG).
Who is sponsoring clinical trial NCT00002791?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia